Unreasonable
VC Fund
Boulder, United States
Unreasonable is a VC fund in Boulder focused on Biotechnology and Information Technology. Unreasonable exists to re-purpose capitalism. We are an international company that supports a Fellowship for growth-stage entrepreneurs, channels exclusive deal-flow to investors, and partners with institutions to discover profit in solving global problems.The 249 ventures in the Unreasonable Fellowship operate across more than 180 countries,have collectively generated $3.6 billion in revenue, raised $4.7 billion in financing, and are positively impacting the lives of more than 530 million people.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $90k
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Unreasonable invests in
Stages Unreasonable invests in
Countries Unreasonable invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 18 contacts → | |||
Investment Focus
Industry
- Biotechnology 3 (20%)
- Information Technology 3 (20%)
- Artificial Intelligence 3 (20%)
- Medical 2 (13%)
- Software 2 (13%)
Stage
- Series B 5 (33%)
- Series A 3 (20%)
- Venture - Series Unknown 3 (20%)
- Series C 2 (13%)
- Seed 1 (7%)
Country
- United States 7 (47%)
- United Kingdom 3 (20%)
- India 1 (7%)
- Japan 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Krating Poonpol
Founding Member
|
Founding Member | Total investments: 9 | Find email | |
Neeta Rastogi Singh
CFO / COO
|
CFO / COO | Total investments: 1 | Find email | |
Bhanu Potta
Unreasonable Mentor
|
Unreasonable Mentor | Total investments: 0 | Find email | |
Brendan Richardson
Unreasonable Fellow
|
Unreasonable Fellow | Total investments: 1 | Find email | |
Christiana Wyly
Chairwoman, Board Of Directors
|
Chairwoman, Board Of Directors | Total investments: 3 | Find email | |
| See all 18 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for manycancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis. | $24.4M / Series D / Aug 18, 2026 | ||
| Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for manycancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis. | $22M / Series C / Dec 05, 2024 | ||
| GALY develops biomaterials through biotechnology and synthetic biology in order to discover new ways to produce natural things. The company was founded in 2016 and is headquartered in Amherst, Massachusetts. | $33M / Series B / Sep 03, 2024 | ||
| Smarter Sorting is an AI tool for regulatory compliance, product data automation, and hazardous-waste reduction. | $637K / Venture - Series Unknown / Aug 14, 2023 | ||
| Dendra's vision is to empower humanity to restore the balance of our natural world. Our mission is to create the tools needed to power scalable ecosystem restoration. | $11.4M / Series A / Jun 08, 2023 | ||
| BlocPower is an energy technology startup that develops healthier, greener, and smarter buildings.It leverages advanced technologies, innovative electrification equipment, and structured finance to provide green heating and cooling to urban buildings. The company also connects government agencies, utilities, building owners, and smart equipmentproviders to identify unhealthy, energy-wasting buildings to retrofit. Its proprietary machine learning platform then determines which retrofits will produce the most energy savings at scale and uses the cloud and IoT to gather data and remotely monitor energy consumption. Since its founding, BlocPower has completed energy projects in nearly 1,000 buildings and delivered results ahead of schedule and under budget. It utilizes its proprietary software for analysis, leasing, project management, and monitoring of urban clean energy projects, and its customers are saving 20–40% on their energy bills each year. The company is backed by top investors, including Kapor Capital, Andreessen Horowitz, the American Family Insurance Institute for Corporate and Social Impact, AccelR8, the Goldman Sachs Urban Investment Group, Elemental Excelerator, CityRock Venture Partners, the Schmidt Family Foundation, and Salesforce Ventures.Donnel Baird and Morris Cox co-founded the company in Brooklyn, New York in 2014. | $24M / Series B / Feb 28, 2023 | ||
| Cabinet Health is a sustainable healthcare company, starting with over-the-counter medicine. Cabinet sells 30+ OTC medicines and dietary supplements with a focus on environmental sustainability, quality, and personalized care. | $17M / Venture - Series Unknown / Dec 15, 2022 | ||
| Airex is a smart ventilation control that builds intelligent air ventilation units using atmospheric sensors and cloud algorithms. The company develops a retrofit smart ventilation control system that controls the airflow through air-bricks. Through it, owners will benefit from decreased energy bills, warmer homes, enhanced thermal comfort, healthyhome, and minimal disturbance without compromising on air quality. The smart algorithms allow automatic air flow regulation while taking into account local weather and air quality data.Airex was founded on 2016 and is headquartered in London. | $3.2M / Series A / Dec 12, 2022 | ||
| Plant Prefab designs and builds custom, sustainable, single-family and multi-family homes for individuals, architects, and developers—twice as fast as site-based builders.Plant Prefab homes are meticulously crafted, and built according to its clients' exact design specifications.Plant Prefab homes are constructed in half the time of asite-built home. Building in a controlled environment, in parallel with site work, reduces delays and waste.Plant Prefab's off-site construction and a patented building system helps it build custom homes much faster and more efficiently than site-based contractors and other prefabricators. The company's rigorous health and sustainability standards means Plant homes are as healthy as possible for its clients and the environment. | $44M / Series C / Dec 02, 2022 | ||
| EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like living bone graft. EpiBone is strategically positioned to provide a superiorbone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year. | Venture - Series Unknown / Nov 26, 2022 | ||
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Unreasonable invest in?
Unreasonable invests primarily in Biotechnology, Information Technology and Artificial Intelligence startups, most often at Series B and Series A stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Unreasonable?
Public channels for Unreasonable include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Unreasonable?
The team at Unreasonable includes Krating Poonpol (Founding Member), Neeta Rastogi Singh (CFO / COO) and Bhanu Potta (Unreasonable Mentor), among 18 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
